Reconciliation of Net Loss Attributable to Cardiac Science Corporation to | ||||||
Pro Forma Net Loss Attributable to Cardiac Science Corporation | ||||||
Three Months Ended | Three Months Ended | |||||
June 30, 2010 | June 30, 2009 | |||||
% of revenue | % of revenue | |||||
| Net loss attributable to Cardiac Science Corporation | $ (18,510) | -51.3% | $ (2,106) | -5.8% | ||
| Corrective action costs | 11,000 | 30.5% | - | 0.0% | ||
| Tax effect | - | n/m | - | n/m | ||
Pro forma net loss attributable to Cardiac Science Corporation | $ (7,510) | -20.8% | $ (2,106) | -5.8% | ||
| CSCX-F | ||||||
